PREFORMULATION STUDIES OF NIOSOMAL GEL CONTAINING DIPIVEFRIN HYDROCHLORIDE FOR ANTIGLAUCOMATIC ACTIVITY
DOI:
https://doi.org/10.22159/ijpps.2024v16i2.49174Keywords:
Dipivefrin hydrochloride, Preformulation, Ocular delivery, Spectrometric analysis, CompatibilityAbstract
Objective: The present study was focused on developing and characterizing niosomal gel formulations for ocular controlled delivery of an adrenergic agonist; dipivefrin HCl. In the present study, the pre-formulation studies are showed towards the development of Novel formulation.
Methods: Preformulation studies of drug were carried out for identification (physical appearance, melting point and UV spectrophotometric analysis), solubility profile, lipophilicity (Partition Coefficient), compatibility studies by FTIR and thermal behavior by DSC.
Results: The melting point of dipivefrin HCl was found to be 147.6±3 °C. The log P value was found to be 3.14±0.02, from which it can be interpreted that drug is highly lipophilic in nature. The scanned λmax were found to be 254 nm. No significant changes were found when FTIR spectra of the physical mixture compared with FTIR spectra of pure drug and excipients. This indicates absence of any possible interaction between the drug and excipients which confirms the identity and purity of drug. DSC thermogram of pure drug showed a sharp exothermic peak at 131.202 °C (area=1726.267 mJ, delta H=575.422 J/g), indicating the crystal melting point of the drug.
Conclusion: These results suggest that the dipivefrin HCl serve as suitable candidate for ocular drug delivery system.
Downloads
References
Chaurasia G. A review on pharmaceutical preformulation studies in formulation and development of new drug molecules. Int J Pharm Sci Res. 2016 Jun 22;7(6):2313-20.
Almeida H, Amaral MH, Lobao P, Lobo JM. In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations. Drug Discov Today. 2014 Apr 21;19(4):400-12. doi: 10.1016/j.drudis.2013.10.001, PMID 24120893.
Anderson JA, Davis WL, Wei CP. Site of ocular hydrolysis of a prodrug, dipivefrin, and a comparison of its ocular metabolism with that of the parent compound, epinephrine. Invest Ophthalmol Vis Sci. 1980 Jul 03;19(7):817-23. PMID 7390729.
Yablonski ME, Shin DH, Kolker AE, Kass M, Becker B. Dipivefrin use in patients with intolerance to topically applied epinephrine. Arch Ophthalmol. 1977 Dec 25;95(12):2157-8. doi: 10.1001/archopht.1977.04450120063004, PMID 588107.
Blondeau P, Cote M. Cardiovascular effects of epinephrine and dipivefrin in patients using timolol: a single-dose study. Can J Ophthalmol. 1984 Feb 20;19(1):29-32. PMID 6713266.
Barot M, Bagui M, Gokulgandhi MR, Mitra AK. Prodrug strategies in ocular drug delivery. Med Chem. 2012 Jul 19;8(4):753-68. doi: 10.2174/157340612801216283, PMID 22530907.
Mandell AI, Stentz F, Kitabchi AE. Dipivalyl epinephrine: a new pro-drug in the treatment of glaucoma. Ophthalmology. 1978 Mar 15;85(3):268-75. doi: 10.1016/s0161-6420(78)35668-2, PMID 662280.
Alshamsan A, Abul Kalam M, Vakili MR, Binkhathlan Z, Raish M, Ali R. Treatment of endotoxin-induced uveitis by topical application of cyclosporine a-loaded PolyGel™ in rabbit eyes. Int J Pharm. 2019;569:118573. doi: 10.1016/j.ijpharm.2019.118573, PMID 31356955.
Tomar S, Singhal T. Preformulation studies of niosomal gel of prednisolone and azithromycin for topical drug delivery system. J Innov Pharm Biol Sci. 2015 Jan 29;2(3):312-21.
Jain N, Verma A. Preformulation studies of pilocarpine hydrochloride as niosomal gels for ocular drug delivery. Asian J Pharm Clin Res. 2020 Apr 18;13(6):149-55. doi: 10.22159/ajpcr.2020.v13i6.37523.
United States Pharmacopeia. National formulary. The official compendia of standards. United States Pharmacopeial Commission; 2007.
Jayanthi B, Madhusudhan S, Mohanta GP, Manna PK. Preformulation, characterisation, designing and formulation of aceclofenac-loaded microparticles. Int J Drug Dev Res. 2012 Jul-Sep;4(3):186-96.
Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy. 3rd ed. Mumbai: Varghese Publishing House; 1987.
Berthod A, Carda Broch SC. Determination ofliquid–liquid partition coefficients by separation methods. J Chromatogr A. 2004 May 22;1037(1-2):3-14. doi: 10.1016/j.chroma.2004.01.001, PMID 15214657.
Jain N, Verma A, Jain N. In vitro evaluation of niosomal gel containing pilocarpine hydrochloride for ocular delivery. Lat Am J Pharm. 2020 Mar 28;39(3):431-8.
Meylan WM, Howard PH. Atom/fragment contribution method for estimating octanol-water partition coefficients. J Pharm Sci. 1995 Jan 06;84(1):83-92. doi: 10.1002/jps.2600840120, PMID 7714751.
Jain N, Banik A, Gupta A. Novel interpenetrating polymer network microspheres of Lepidium sativum and poly(vinyl alcohol) for the controlled release of simvastatin. Int J Pharm Pharm Sci. 2013 Jan 13;5(1):125-30.
Jain N, Singh N, Sharma U, Jain N, Dwivedi S. Fabrication and characterization of novel antiulcer drug delivery system: LBG/PVA based interpenetrating polymer network (IPN) mucoadhesive microspheres of famotidine. Lat Am J Pharm. 2021 Dec 19;40(12):2862-72.
Published
How to Cite
Issue
Section
Copyright (c) 2024 NEERAJ JAIN, ANURAG VERMA, NEELAM JAIN
This work is licensed under a Creative Commons Attribution 4.0 International License.
